Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Miles Prince

Showing results (1-10 of 317) with videos related to

Pageof 32
Sort By:
Leukemia Research|January 10, 2012
Fludarabine and a histone deacetylase inhibitor - strange bedfellowsH Miles Prince
Leukemia & Lymphoma|January 21, 2012
Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trialsH Miles Prince
Blood|November 8, 2014
Identifying mutant pathways in the histiocytosesH Miles Prince
British Journal of Haematology|August 10, 2021
A cautionary tale of the use of lenalidomide and dexamethasone for relapsed/refractory immunoglobulin light chain (AL) amyloidosisH Miles Prince
Blood|October 12, 2023
Blocked addiction to IL-15 for treating T-LGLLH Miles Prince
Investigational New Drugs|December 4, 2010
The deacetylase inhibitors--here to stay!H Miles Prince
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015
CD30 As a Target for the Treatment of Cutaneous T-Cell LymphomaH Miles Prince
Leukemia & Lymphoma|June 4, 2013
Are we close to a prognostic index for cutaneous T cell lymphoma?H Miles Prince
Leukemia & Lymphoma|November 17, 2006
Myeloma, thalidomide and thrombosisDirk Hönemann, H Miles Prince
Leukemia & Lymphoma|November 17, 2006
The troublesome toxicity of peripheral neuropathy with thalidomideLinda Mileshkin, H Miles Prince
Pageof 32

Showing results (1-10 of 317) with videos related to

Sort By:
Pageof 32
Leukemia Research|January 10, 2012
Fludarabine and a histone deacetylase inhibitor - strange bedfellowsH Miles Prince
Leukemia & Lymphoma|January 21, 2012
Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trialsH Miles Prince
Blood|November 8, 2014
Identifying mutant pathways in the histiocytosesH Miles Prince
British Journal of Haematology|August 10, 2021
A cautionary tale of the use of lenalidomide and dexamethasone for relapsed/refractory immunoglobulin light chain (AL) amyloidosisH Miles Prince
Blood|October 12, 2023
Blocked addiction to IL-15 for treating T-LGLLH Miles Prince
Investigational New Drugs|December 4, 2010
The deacetylase inhibitors--here to stay!H Miles Prince
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015
CD30 As a Target for the Treatment of Cutaneous T-Cell LymphomaH Miles Prince
Leukemia & Lymphoma|June 4, 2013
Are we close to a prognostic index for cutaneous T cell lymphoma?H Miles Prince
Leukemia & Lymphoma|November 17, 2006
Myeloma, thalidomide and thrombosisDirk Hönemann, H Miles Prince
Leukemia & Lymphoma|November 17, 2006
The troublesome toxicity of peripheral neuropathy with thalidomideLinda Mileshkin, H Miles Prince
Pageof 32